Stanford researchers have developed an innovative, mechanically tunable microneedle applicator that enables consistent and reliable insertion of microneedle arrays into skin for drug delivery, diagnostics, and sampling applications.
Stanford researchers have developed an innovative vacuum-integrated microneedle platform designed to enable efficient and reliable collection of dermal interstitial fluid (ISF) for diagnostic and biomarker analysis.
Researchers from Stanford have developed a novel topical pharmaceutical composition comprising of a chemical inhibitor encapsulated in nanomicelles for the treatment of vision loss associated with acute optic neuropathies.
Researchers at Stanford University have developed a compact insulin pump for continuous subcutaneous insulin infusion (CSII) that addresses a core limitation of many commercial pumps: device size driven by piston-based mechanics.
Stanford researchers have developed a specialized bone graft delivery device that can efficiently transport and implant fragmented bone grafts or therapeutics into narrow bone tunnels without disintegration.
Researchers in Professor Justin Sonnenburg's laboratory have developed genetic tools for manipulating Bacteroides, a prominent genus of gut bacteria, for imaging, diagnostics, and therapeutic drug delivery.
The Stanford team developed a versatile injectable alginate-collagen hydrogel, a significant advancement in regenerative medicine and targeted therapeutic delivery.
Stanford researchers have repurposed two existing drugs and created a combined nanoparticle formulation that provides both intraocular pressure management and neuroprotection for glaucoma therapy.
Researchers at Stanford University have found that recombinant osteopontin (SPP1) protein reduces foreign body response (FBR) and thereby facilitates successful integration and function of implantable devices.
Researchers at Stanford have identified the use of the drug verteporfin to treat or reduce the risk of developing ibrosis after ocular procedures or ocular injury. Of interest is corneal injury, for example after refractive surgery or crosslinking, e.g.
Stanford scientists have developed a novel approach to help patients with short bowel syndrome by using intestinal lengthening. The solution involves injecting a degradable hydrogel into the intestinal wall to narrow the lumen and enable the confinement of a coiled spring.
To manage the development and progression of glaucoma, researchers at Stanford University have developed a biocompatible suprachoroidal spacer implant.
Researchers at Stanford University have formulated a novel biomaterial suitable for three-dimensional (3D) bioprinting: a homogeneous composite of polycaprolactone (PCL), gelatin, and beta-tricalcium phosphate.
Stanford researchers develop a surgical technique to access the optical nerve head from tunneling through the suprachoroidal space (SCS) for drug delivery applications.